PrestoDoctor

SEPTEMBER 6, 2023

Codeine works by binding to opioid receptors in the brain, blocking pain signals and providing a sense of relief. Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Project CBD

JANUARY 24, 2019

Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs). Previous research has found that THC may be effective for some cases that do not respond well to Ritalin. . Self medicating for endometriosis.

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. For this reason, the compound was abandoned by its developer and never marketed.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

CannaMD

NOVEMBER 4, 2020

Cannabis has been used for centuries to manage chronic pain from all sources and, as a recent study highlights, its positive effects extend to migraines. Other Research Findings. The present study relied on Migraine Buddy , a leading mobile application that tracks migraine symptoms. Of the 40 million sufferers in the U.S.,

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. As patients became addicted to their pain meds and couldn’t secure refills, they began turning to illicit opioids like heroin and fentanyl. A Better Alternative for Chronic Pain.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Doctors prescribe various forms of opiods to cancer patients for pain. Spain researches advanced use of cannabis medications.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Veriheal

APRIL 26, 2022

Growth of the worldwide legal cannabis market is unlikely to slow down anytime soon, according to the findings of a new report published by analysts at Research and Markets. This currency exchange data is provided as a means of assisting industry leaders in making informed business-related decisions. billion by 2026.

Supply Chain 97

Supply Chain Legalization Research and Development Chronic Pain 97

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future.

Research and Development 98

Research and Development Treatment Media Medicine 98

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Doctors prescribe various forms of opiods to cancer patients for pain. Spain researches advanced use of cannabis medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Cannigma

JULY 1, 2021

The study was developed by People Science , a tech-enabled science company that is focused on connecting “health minded people, research scientists, and healthcare providers in an effort to unlock the potential of alternative medicines,” according to People Science. One of the tools to try to tackle sleep and wellness”.

Sleep 101

Sleep Edibles Research and Development Data 101

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

JULY 20, 2021

While states across the country consider how best to address the mental health and opioid crisis facing our nation, psychedelic medicines are being extensively researched and reported as being a game-changing therapy for PTSD, suicide, chronic pain, and other illnesses.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Weedistry

JANUARY 28, 2019

The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Otherside Farms

JULY 4, 2022

Reduce Chronic Pain. CBC Isolate reduced osteoarthritis pain in 2011. In this study, researchers examined studied Bulk CBC Isolate and paw edema. The researchers studied adult mice neural stem progenitor cells (NSPCs) outside the body. The 1980s saw some of the best CBC Isolate research. Antibacterial.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

Cannabis Law Report

APRIL 4, 2019

House of Hemp hope to build on existing medical research and further explore the potential of cannabis as a healing plant. Limited evidence suggests cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

Cannabis Law Report

MAY 14, 2022

In drilling down the issue, a lack of UK-based research as to the efficacy of CBPMs is the starting point. Several laudable initiatives have sought to plug the research gap, including Project Twenty21, which is the UK’s largest observational medicinal cannabis study.

Access 52

Access CBD Research and Development Medicine 52

Cannabis Law Report

JULY 13, 2021

Inhalation of cannabis extracts allows for a faster onset and higher bioavailability than tinctures and oils, and now that doctors can monitor a patient’s metered-dosage, more accurate patient data. This is the start of a revolution in medical cannabis application and we are delighted to be supplying it under the NOIDECS* brand.”.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. The immediate next steps are to submit data for ethics committee review and approval whereupon acceptance, further details will be provided.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 24, 2022

According to experts, research with psychedelics (also known as hallucinogens) or related substances will increase worldwide in the coming years. Switzerland is a leader in the research and use of psychedelics in psychiatry and is considered an innovation driver in this field. scientific research, (2.) percent annually to $9.8

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

JUNE 24, 2021

The antibiotic and analgesic effects & properties present in Cannabidiol, which can be used to treat a variety of ailments such as anxiety, nausea, stress, chronic pain, neurological conditions, and seizures, are likely to contribute to the growth of the market. The projections are calculated using proven research methodologies.

Research and Development 78

Research and Development Tincture Chronic Pain Pharmaceutical 78

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

Cannabis Law Report

SEPTEMBER 13, 2021

Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.”. MYMD-1 is being developed to treat aging and longevity, autoimmune diseases, and COVID-19- associated depression and cytokine elevation. Chief Scientific Officer. MyMD Pharmaceuticals, Inc.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

MARCH 19, 2020

This advisory provides an overview of key regulatory activity and priorities that should be on the radar of any company engaged in the development or sale of products that contain CBD. In the absence of federal action, states have developed their own regulatory schemes. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

Some researchers believe that cannabis can increase both creativity and productivity. [1] In fact, many successful people credit marijuana with helping them develop the very traits, habits, creativity, and skills that led to their success. In short, it is a difficult claim to find direct research to support. 1] Malceva, M.,

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Sensi Seeds

JANUARY 4, 2019

Its arguments are that there is insufficient clinical evidence about the medicinal benefits of cannabis, and that available data on indications, potency (THC, CBD levels) drug interactions and adverse effects are still too few. There is need for further research.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

OCTOBER 26, 2021

MyMD’s lead drug candidate, MYMD-1, is being developed to target aging and related diseases along with autoimmune diseases including rheumatoid arthritis. MyMD’s lead drug candidate, MYMD-1, is being developed to target aging, aging-related diseases, and autoimmune diseases including rheumatoid arthritis. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 30, 2019

Then the context in which marijuana is researched and discussed in public can shift. For now, both Florida’s restrictions and federal restrictions on the scheduling of cannabis still apply as states scramble to formulate respective regulations for research, access, education, innovation.

Marijuana 40

Marijuana Education Patients Research and Development 40

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer. In October 2021, Virpax announced that a $1.87

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Veriheal

AUGUST 31, 2021

Essay Summary: Sandeep conceptualizes a strain recommendation app in which consumers can create a profile and review strains and their effects (help with sleep, back pain, migraines, etc.). The app would also provide data to producers and distributors to identify trends in the market to better serve the needs of consumers. .

Research and Development 116

Research and Development Supply Chain Programs Education 116

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”). The studies are expected to begin in January of 2022.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52